This 2009 study by Avena, Rada, and Hoebel examines the distinct neurochemical and behavioral effects of sugar and fat bingeing in animal models. Both nutrients activate the mesolimbic dopamine system, but sugar bingeing leads to behaviors akin to addiction, including withdrawal symptoms, increased dopamine release, and opioid-like effects. In contrast,
This 2008 review by Avena, Rada, and Hoebel examines whether sugar can elicit addictive behaviors and neurochemical changes similar to those caused by drugs of abuse. Using an animal model, the study identifies four key components of addiction—bingeing, withdrawal, craving, and cross-sensitization—demonstrated through intermittent, excessive sugar intake. Neurochemical analyses reveal
This preclinical study examined the effects of bremelanotide, an α-MSH analogue, on sexual desire in female rats, focusing on its impact on specific brain regions. Results showed that bremelanotide significantly increased solicitation behaviors, an indicator of heightened sexual desire, without affecting pacing or lordosis. These effects were linked to activation
This in vivo animal study investigated the neuroprotective effects of L-deprenyl against rotenone-induced dopaminergic neurodegeneration in rats. Rotenone, a mitochondrial complex-I inhibitor, induces oxidative stress and neuronal damage, mimicking Parkinson’s disease pathology. L-deprenyl treatment significantly reduced oxidative stress markers, preserved dopaminergic neurons in the substantia nigra, decreased lipid peroxidation, and
